Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)

NCT00067093 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1452

Enrollment

INDUSTRY

Sponsor class

Conditions

Deep Vein Thrombosis

Interventions

DRUG: SanOrg34006
DRUG: LMW heparin
DRUG: Unfractionated heparin
DRUG: Vitamin K antagonist (VKA)

Sponsor

Sanofi